BackBiostar Pharmaceuticals Overview

Biostar Pharmaceuticals Current Cash

Biostar Pharmaceuticals's current cash is $360K.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$364973.00
↓ 44.65% YoYΔ $-294386.00 vs prior year quarter

Peer trimmed avg / median

Loading

Biostar Pharmaceuticals Current Cash History

Loading

Biostar Pharmaceuticals vs. peers: Current Cash Comparison

Loading

Biostar Pharmaceuticals Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Biostar Pharmaceuticals (BSPM) FAQ

Biostar Pharmaceuticals (BSPM) currently reports a current cash of $360K as of September 2017. That compares with $660K in the prior-year period — down 44.6% year over year. Use the charts on this page to explore Biostar Pharmaceuticals's current cash history and peer comparisons.

Biostar Pharmaceuticals's current cash decreased from $660K to $360K — a 44.6% year-over-year decrease (period ending September 2017). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biostar Pharmaceuticals reported $360K in current cash as of September 2017. That compares with $660K in the prior-year period — down 44.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $360K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Biostar Pharmaceuticals, and consider following BSPM for alerts when major investors trade the stock.